Literature DB >> 29249595

Is Emergency Transcatheter Hepatic Arterial Embolization Suitable for Spontaneously Ruptured Hepatocellular Carcinoma in Child-Pugh C Cirrhosis?

Wen-Zhe Fan1, Ying-Qiang Zhang1, Wang Yao1, Yu Wang1, Guo-Sheng Tan2, Yong-Hui Huang2, Jian-Yong Yang3, Jia-Ping Li4.   

Abstract

PURPOSE: To evaluate the utility of emergent transcatheter arterial embolization for spontaneously ruptured hepatocellular carcinoma (HCC) in patients with Child-Pugh class C (CPC) liver cirrhosis presenting hemorrhagic shock.
MATERIALS AND METHODS: A study of all 94 patients was retrospectively conducted from January 2006 to January 2016. Sixty patients underwent conservative treatment (control group) and 34 underwent embolization.
RESULTS: Embolization provided better stabilization of hemodynamic status than conservative treatment (91.2% vs 61.7%), with greater overall survival (OS) rates at 30, 60, and 120 days (73.5%, 52.9%, and 29.4% vs 33.3%, 13.3%, and 0%, respectively). Mean follow-up duration was 51.07 days (range, 3-237 d). Median survival time was longer for the embolization group than the control group, specifically for patients with a shock index (SI) of ≥ 0.6 to < 1 (106.0 d ± 39.4 vs 34.0 d ± 4.7) or ≥ 1 (18.0 d ± 7.5 vs 11.0 d ± 3.2), those with CPC scores 10 or 11 (88.0 d ± 29.4 vs 28.0 d ± 4.5), and those with segmental (165.0 d ± 20.6 vs 34.0 d ± 9.7) or lobar (54.0 d ± 7.9 vs 26.0 d ± 3.4) portal vein tumor thrombus (PVTT). SI ≥ 1, Child-Pugh score of 12/13, tumor size ≥ 10 cm, and PVTT were independent factors in poor prognosis for OS.
CONCLUSIONS: Emergent transcatheter arterial embolization is an effective intervention for ruptured HCC in patients with CPC liver function in hemorrhagic shock, particularly those with a SI ≥ 1, Child-Pugh scores of 10/11, and first- or lower-order PVTT.
Copyright © 2017 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29249595     DOI: 10.1016/j.jvir.2017.09.022

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  4 in total

1.  Treatment strategies and prognosis for initially unresectable ruptured hepatocellular carcinoma: a single-center experience in 94 patients.

Authors:  Chun Zhou; Qing-Quan Zu; Xing-Long Liu; Bin Wang; Chun-Gao Zhou; Hai-Bin Shi; Sheng Liu
Journal:  Diagn Interv Radiol       Date:  2020-05       Impact factor: 2.630

2.  Development and Validation of Artificial Neural Networks for Survival Prediction Model for Patients with Spontaneous Hepatocellular Carcinoma Rupture After Transcatheter Arterial Embolization.

Authors:  Yiwen Qiu; Tao Wang; Xianwei Yang; Shu Shen; Yi Yang; Wentao Wang
Journal:  Cancer Manag Res       Date:  2021-09-27       Impact factor: 3.989

3.  Prognostic Analysis of Postoperative Survival for Ruptured Hepatocellular Carcinoma with or without Cirrhosis.

Authors:  Feng Xia; Peng Zhu; Xiao-Ping Chen; Bi-Xiang Zhang; Ming-Yu Zhang
Journal:  J Oncol       Date:  2022-03-17       Impact factor: 4.375

4.  Research progress of spontaneous ruptured hepatocellular carcinoma: Systematic review and meta-analysis.

Authors:  Chunling Wang; Xiaozhun Huang; Xiaofeng Lan; Dongmei Lan; Zhangkan Huang; Shu Ye; Yihong Ran; Xinyu Bi; Jianguo Zhou; Xu Che
Journal:  Front Oncol       Date:  2022-09-29       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.